About VACCINE

VACCINE's goal is to help this nation's 2.3 million extended homeland security personnel, including first-responders, perform their jobs more effectively by turning mass amounts of data into manageable information.

Turning massive data into actionable knowledge through innovative visual analytic techniques is vital to the mission of the Command, Control, and Interoperability (CCI) Division of The Department of Homeland Security, as well as all of the mission areas of DHS.

VACCINE Anual Report - Year Three can now be viewed below

• VACCINE Period 3 Annual Report
• Addendum A-Presentations
• Addendum B-Publications
• Addendum C-Various Reports

Research

The overall goal of our research is to create innovative and effective integrated data and visual analytic environments-frameworks, methods, and software-that advance the start-of-the-art in analyzing massive, heterogeneous, incomplete, temporally evolving homeland security data for anticipating, detecting, and responding to DHS mission needs.

Education

VACCINE's goal is to educate current homeland security stakeholders and the next generation of talent and enable them to make effective decisions from the mass of multisource, multimedia data they will face in their careers. Our educational initiatives span the entire career development pipline ranging from PK-12 programs through undergraduate and graduate level work, to professional education and training programs.

Announcements

VACCINE REQUEST FOR PROPOSALS for E2E Seed Project Funding Year 4

Submission Deadline: May 25, 2012 to: vaccine@purdue.edu

VACCINE is now considering applications for E2E seed projects  fro Year 4 funding.   Projects will be selected through a peer-review process led by the VACCINE Leadership Board. Proposals  should focus on the relationship to the E2E initiative as outlined by DHS and should be relevant to the specific E2E projects outlined by VACCINE . Although the seed competition is open to all institutions, priority will be given to those who have a proven track record of innovation and have prior experience in delivering technology to DHS clients.

Forms and Instructions:

VACCINE Supplemental Funding Guidelines

Seed Funding Evaluation Criteria

Seed Project Application Form

Proposed Budget Form

For additional information, please contact:
David Ebert, VACCINE Director, (765) 494-9064, ebertd@purdue.edu

VACCINE Receives Mira Award of Excellence and Innovation 

TechPoint, Indiana's technology growth initiative, has announced the Finalists for its 13th annual Mira Awards presented by BKD CPAs & Advisors. Finalists in seven different technology categories will deliver presentations and answer questions during interviews with independent judging panels later this week.

This year's Mira Awards finalists criss-cross the marketplace from established corporations and preeminent research institutions to fledgling startups, and from creative agencies to high-tech laboratories and emerging technologies.  Read More

VACCINE Technology Enhances Student-Driven Learning Website

Students at Purdue University are developing their own learning website (www.projectrhea.org).  Called “Rhea” after the flightless bird of the ratite family, the project began in 2007 under the initiative of Mimi Boutin, associate professor of electrical and computer engineering at Purdue and member of the VACCINE faculty research team. “Rhea was originally created because students felt their courses needed to be better connected to each other, and better connected to the real world,” says Prof. Boutin. “Student volunteers proposed to address this problem with a campus-wide wiki that could be used to share learning material created by students. Other tools were successively added to the website, such as a dropbox for electronic homework collection and a double-blind peer review system for homework and project grading,” she said.  Read more.